UK economy: encouraging forecast by IMF
The IMF has forecast that the UK will be the second-fastest-growing economy among the G7 nations this year - behind only the USA - despite ongoing global trade tensions. The IMF projects UK growth at a modest 1.3% in both 2025 and 2026, signaling resilience but also stagnation compared with past performance. Per capita growth, at less than 0.5%, remains the weakest in the G7. Inflation, however, continues to cloud the outlook: the UK is expected to record the highest price rises among advanced economies, driven by elevated energy and utility costs. The IMF anticipates inflation will ease to 2% by late next year, yet households still face financial strain. Rachel Reeves, attending the IMF’s Washington meetings, pledged to tackle what she called a ‘stuck’ economy, while the Bank of England urged caution on rate cuts. Amid geopolitical uncertainty and trade disruptions, Britain’s challenge is how to sustain growth without deepening inequality. Reeves has recently hinted that she may raise some taxes in the November budget: see
NHS: will new cell therapy be a game-changer?
Scientists are pioneering a revolutionary cell therapy that could make the current treatments of autoimmune diseases such as Crohn’s disease and multiple sclerosis obsolete: Led by Professor Ye Htun Oo at the University of Birmingham, the project uses a patient’s own regulatory T cells to retrain the immune system, combating harmful autoimmune responses which lead to organ failure. This innovative approach may soon replace traditional treatments which often cause serious side effects such as hypertension, diabetes, and cancer risk. With more than 8,000 people currently awaiting transplants in the UK, and each procedure costing up to £100,000, the potential savings to the NHS are immense. The therapy, expected to be available within a decade, could transform the treatment of autoimmune liver disease and related conditions, offering hope for longer, healthier lives without dependency on harsh medications. While further trials are needed, experts describe this research as a ‘game-changer’ for modern medicine.
Controversial proposed oil field publishes climate impact figures
The full environmental impact of the proposed Rosebank oil field, the UK’s largest undeveloped fossil fuel site some eighty miles north-west of Shetland, has now been revealed - and it is vast. The developers, Equinor and Ithaca Energy, have admitted that burning Rosebank’s oil and gas could release nearly 250 million tonnes of carbon dioxide over 25 years, equivalent to two-thirds of the UK’s current annual emissions. The figure, which dwarfs earlier estimates, follows a court ruling requiring a full assessment of the climate impact not just of extraction, but of using the fuels themselves. Environmental groups, including Greenpeace and Uplift, call the figures a stark warning that Rosebank is incompatible with Britain’s 2050 net-zero goal. The Government’s final decision, due after public consultation closes in November, will test its climate credibility. While the developers claim the emissions are ‘not significant’, critics insist that approving Rosebank would lock the UK into decades of pollution and contradict its clean energy ambitions.
Scotland: doctors query Swinney’s plan for walk-in health centres
Scottish first minister John Swinney’s plan to launch 15 new GP- and nurse-led walk-in health centres has sparked debate among medical leaders about staffing and feasibility. The proposal aims to ease the ‘8 am rush’ for appointments by offering no-booking consultations from noon to 8 pm, seven days a week, potentially adding a million more appointments annually. However, doctors’ groups, including the Royal College of General Practitioners (RCGP) in Scotland, say they were not consulted and question how the services will be staffed given a declining full-time GP workforce. Although the number of doctors in Scotland has risen slightly since 2015, many now work part-time, and the number of GP practices has fallen by 10%. Health secretary Neil Gray insists Scotland’s record 1,200 GP trainees can help fill gaps, but critics warn that workforce pressures and unclear logistics could limit the scheme’s success. The initiative highlights growing tension between political ambition and the realities of primary care delivery.
